Institutional Portfolio Favorite in Spotlight: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
They expect $-0.59 EPS, up 9.23 % or $0.06 from last year's $-0.65 per share. For the full year, analysts expect earnings to decline -100.18% yoy to -$1.8. RSI is a technical indicator of price moment...